A study to see whether an injection near the back of the head (greater occipital nerve block) can help reduce pain and headache days in people with chronic migraine

Efficacy of Greater Occipital Nerve Intervention in Managing Chronic Migraine Headache - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096122

Enrollment

Registered

2025-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura

Interventions

Intervention1: Greater occipital nerve intervention: A single session of ultrasound-guided unilateral greater occipital nerve block will be performed on the symptomatic side. Under full aseptic precau

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults aged 18–65 years. 2. Diagnosed with chronic migraine according to ICHD-3 . 3. Willing to give informed consent

Exclusion criteria

Exclusion criteria: 1.Secondary headache disorders. 2.Local infection at injection site. 3.Coagulopathy or anticoagulant use. 4.Known allergy to lignocaine or corticosteroids. 5.Pregnancy or lactation. 6.Severe psychiatric or cognitive impairment affecting compliance.

Design outcomes

Primary

Measure	Time frame
Reduction in mean pain intensity score after ultrasound-guided unilateral greater occipital nerve blockTimepoint: Baseline , 4th week	—

Secondary

Measure	Time frame
1. Reduction in migraine frequency. 2. Change in medication quantification scale. 3.Improvement in quality of lifeTimepoint: Baseline and 4 weeks post-intervention	—

Countries

India

Contacts

Public ContactAJAY AJAY

AIIMS Gorakhpur

AJAY.PANWAR1307@GMAIL.COM8053250658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026